ReviewACS pharmacology & translational science2022

Nedosiran, a Candidate siRNA Drug for the Treatment of Primary Hyperoxaluria: Design, Development, and Clinical Studies.

Anna Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.